Computer System Validation 2022 - 2-Day Virtual Seminar on Computer System Validation (CSV) and Data Integrity for Clinical Trials Regulated by FDAomputer System Validation (CSV)
Date2022-01-31 - 2022-02-01
Deadline2022-01-30
VenueOnline, USA - United States
KeywordsFDA Compliance; Computer System Validation (CS; Webinar
Topics/Call fo Papers
2-Day Virtual Seminar on Computer System Validation (CSV) and Data Integrity for Clinical Trials Regulated by FDA
Product Id : SEM3149
Category : Seminar
Presenter : Carolyn Troiano
Scheduled On : January 31 2022 11:00 am US/Canada (Eastern Time - ET)
Duration : 2 Days
Computer system validation has been regulated by FDA for more than 30 years, as it relates to systems used in the manufacturing, testing and distribution of a product in the pharmaceutical, biotechnology, medical device or other FDA-regulated industries. The FDA requirements ensure thorough planning, implementation, integration, testing and management of computer systems used to collect, analyze and/or report data.
Electronic records and electronic signatures (ER/ES) came into play through guidelines established by FDA in 1997, and disseminated through 21 CFR Part 11. This code describes the basic requirements for validating and documenting ER/ES capability in systems used in an FDA-regulated environment.
FDA’s recent focus on data integrity during computer system validation inspections and audits has brought this issue to the forefront of importance for compliance of systems used to support clinical trials. These include clinical trial data collection, management and reporting systems, clinical trial sample manufacturing, testing and labeling systems, and all of those systems used in the conduct of the clinical trial which generate documentation for the clinical Trial Master File (TMF).
Why You Should Attend:
We will explore the best practices and strategic approach for evaluating computer systems used in the conduct of clinical trials and determining the level of compliance, based on validation and data integrity. We will walk through the entire System Development Life Cycle (SDLC) approach to validation of FDA-regulated computer systems, and will also discuss 21 CFR Part 11 and the importance of managing electronic records and signatures appropriately.
We will also walk through the entire set of essential clinical trial files that must be maintained before, during and after completion of the trial in the Trial Master File (TMF). This part of the discussion will also delve into the use of electronic Trial Master File (eTMF) systems and the pros and cons of doing so.
Finally, we will discuss what is needed to prepare for an FDA inspection of computer systems and data used in support of clinical trials. These are extremely valuable assets for any company doing this type of work, and best efforts are necessary to ensure data is maintained in a state of integrity throughout its lifecycle.
Learning Objectives:
Learn how to identify “GxP” Systems
Discuss the Computer System Validation (CSV) approach based on FDA requirements
Learn about the System Development Life Cycle (SDLC) approach to validation
Discuss the best practices for documenting computer system validation efforts, including requirements, design, development, testing and operational maintenance procedures
Understand how to maintain a system in a validated state through the system’s entire life cycle
Learn how to assure the integrity of clinical data that supports trial work
Discuss the importance of “GxP” documentation that complies with FDA requirements
Learn about the policies and procedures needed to support your validation process and ongoing maintenance of your clinical trial systems in a validated state
Understand the key components of 21 CFR Part 11 compliance for electronic records and signatures
Know the regulatory influences that lead to FDA’s current thinking at any given time
Learn how to prepare the essential files for a Trial Master File
Understand how an electronic Trial Master File (eTMF) can improve trial management
Know the clinical data files that are essential to collect before, during and after the conduct of a trial
Learn how to best prepare for an FDA inspection or audit of a clinical trial related computer system.
Who Should Attend:
Clinical Data Analysts
Clinical Data Managers
Clinical Trial Sponsors
Information Technology Analysts
Information Technology Developers and Testers
QC/QA Managers and Analysts
Analytical Chemists
Compliance and Audit Managers
Laboratory Managers
Automation Analysts
Computer System Validation Specialists
GMP Training Specialists
Business Stakeholders/Subject Matter Experts
Business System/Application Testers
This seminar will also benefit any consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance.
Carolyn Troiano
Carolyn Troiano has more than 30 years of experience in computer system validation in the pharmaceutical, medical device, animal health, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.
During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.
Carolyn has participated in industry conferences. She is currently active in the PMI, AITP, and RichTech, and volunteers for the PMI’s Educational Fund as a project management instructor for non-profit organizations.
DAY 1 : (11 AM – 4 PM)
Lecture 1:
– “GxP” Systems
– Computer System Validation (CSV)
– CSV Maintenance
Lecture 2:
– “GxP” Documentation Principles
– Policies and Procedures
Lecture 3:
– 21 CFR Part 11 Overview
– 21 CFR Part 11 Compliance
– FDA Regulatory Compliance
DAY 2 : (11 AM – 4 PM)
Lecture 4:
– Computers and Data Integrity
– Regulatory Influences
– Industry Best Practices
Lecture 5:
– Clinical Trial Master File (TMF)
– Electronic Trial Master File (eTMF)
– Trial Master File Content
– Before the Clinical Trial Begins
– During the Clinical Trial
– After the Clinical Trial
Lecture 6:
– Prepare for a Computer System Audit
Product Id : SEM3149
Category : Seminar
Presenter : Carolyn Troiano
Scheduled On : January 31 2022 11:00 am US/Canada (Eastern Time - ET)
Duration : 2 Days
Computer system validation has been regulated by FDA for more than 30 years, as it relates to systems used in the manufacturing, testing and distribution of a product in the pharmaceutical, biotechnology, medical device or other FDA-regulated industries. The FDA requirements ensure thorough planning, implementation, integration, testing and management of computer systems used to collect, analyze and/or report data.
Electronic records and electronic signatures (ER/ES) came into play through guidelines established by FDA in 1997, and disseminated through 21 CFR Part 11. This code describes the basic requirements for validating and documenting ER/ES capability in systems used in an FDA-regulated environment.
FDA’s recent focus on data integrity during computer system validation inspections and audits has brought this issue to the forefront of importance for compliance of systems used to support clinical trials. These include clinical trial data collection, management and reporting systems, clinical trial sample manufacturing, testing and labeling systems, and all of those systems used in the conduct of the clinical trial which generate documentation for the clinical Trial Master File (TMF).
Why You Should Attend:
We will explore the best practices and strategic approach for evaluating computer systems used in the conduct of clinical trials and determining the level of compliance, based on validation and data integrity. We will walk through the entire System Development Life Cycle (SDLC) approach to validation of FDA-regulated computer systems, and will also discuss 21 CFR Part 11 and the importance of managing electronic records and signatures appropriately.
We will also walk through the entire set of essential clinical trial files that must be maintained before, during and after completion of the trial in the Trial Master File (TMF). This part of the discussion will also delve into the use of electronic Trial Master File (eTMF) systems and the pros and cons of doing so.
Finally, we will discuss what is needed to prepare for an FDA inspection of computer systems and data used in support of clinical trials. These are extremely valuable assets for any company doing this type of work, and best efforts are necessary to ensure data is maintained in a state of integrity throughout its lifecycle.
Learning Objectives:
Learn how to identify “GxP” Systems
Discuss the Computer System Validation (CSV) approach based on FDA requirements
Learn about the System Development Life Cycle (SDLC) approach to validation
Discuss the best practices for documenting computer system validation efforts, including requirements, design, development, testing and operational maintenance procedures
Understand how to maintain a system in a validated state through the system’s entire life cycle
Learn how to assure the integrity of clinical data that supports trial work
Discuss the importance of “GxP” documentation that complies with FDA requirements
Learn about the policies and procedures needed to support your validation process and ongoing maintenance of your clinical trial systems in a validated state
Understand the key components of 21 CFR Part 11 compliance for electronic records and signatures
Know the regulatory influences that lead to FDA’s current thinking at any given time
Learn how to prepare the essential files for a Trial Master File
Understand how an electronic Trial Master File (eTMF) can improve trial management
Know the clinical data files that are essential to collect before, during and after the conduct of a trial
Learn how to best prepare for an FDA inspection or audit of a clinical trial related computer system.
Who Should Attend:
Clinical Data Analysts
Clinical Data Managers
Clinical Trial Sponsors
Information Technology Analysts
Information Technology Developers and Testers
QC/QA Managers and Analysts
Analytical Chemists
Compliance and Audit Managers
Laboratory Managers
Automation Analysts
Computer System Validation Specialists
GMP Training Specialists
Business Stakeholders/Subject Matter Experts
Business System/Application Testers
This seminar will also benefit any consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance.
Carolyn Troiano
Carolyn Troiano has more than 30 years of experience in computer system validation in the pharmaceutical, medical device, animal health, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.
During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.
Carolyn has participated in industry conferences. She is currently active in the PMI, AITP, and RichTech, and volunteers for the PMI’s Educational Fund as a project management instructor for non-profit organizations.
DAY 1 : (11 AM – 4 PM)
Lecture 1:
– “GxP” Systems
– Computer System Validation (CSV)
– CSV Maintenance
Lecture 2:
– “GxP” Documentation Principles
– Policies and Procedures
Lecture 3:
– 21 CFR Part 11 Overview
– 21 CFR Part 11 Compliance
– FDA Regulatory Compliance
DAY 2 : (11 AM – 4 PM)
Lecture 4:
– Computers and Data Integrity
– Regulatory Influences
– Industry Best Practices
Lecture 5:
– Clinical Trial Master File (TMF)
– Electronic Trial Master File (eTMF)
– Trial Master File Content
– Before the Clinical Trial Begins
– During the Clinical Trial
– After the Clinical Trial
Lecture 6:
– Prepare for a Computer System Audit
Other CFPs
- 2-Day Virtual Seminar on SOP Writing, Training and Compliance in the Pharmaceutical Industry
- 4th International Conference on Communication, Computing and Electronics Systems
- 5th International Conference on Advanced Research in Social Sciences (ICARSS)
- 5th International Conference on Advanced Research in Social Sciences (ICARSS)
- 5th International Conference on Advanced Research in Education
Last modified: 2022-01-19 02:14:53